Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence
Open accessPublished version of a preprint
Abstract
Memory B cells specific for SARS-CoV-2 spike and nucleocapsid proteins persist in peripheral blood after recovery from COVID-19.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
SARS-CoV-2-specific memory B cells accumulate over the first few months after initial infection.
“We and others have shown that SARS-CoV-2-specific memory B cells accumulate over the first few months after initial infection2,3,8,9,28 (Fig. 1a)”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [28]
Frequencies of circulating memory B cells continue to increase for several months after recovery from COVID-19 when most other responses decline, suggesting recall of B cell memory may extend antibody-dependent protection despite waning serological titres.
“The observations that frequencies of circulating memory B cells continue to increase for several months after recovery from COVID-19 (refs2,3,8,9,28), when most other responses are declining (Fig. 1a), suggest that recall of B cell memory may provide a mechanism to extend the duration of antibody-dependent protection in the face of waning serological titres.”
From Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection (2021) · cites this paper as [28]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Part of this paper’s reference list could not be split into single entries.
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884 · see citing works
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066 · see citing works
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254 · see citing works
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267 · see citing works
Factors associated with COVID-19-related death using OpenSAFELY
Williamson, E. J., Walker, A. J., Bhaskaran, K., Bacon, S., Bates, C., Morton, C. E., Curtis, H. J., Mehrkar, A., Evans, D., Inglesby, P., et al. (2020) · Nature · doi:10.1038/s41586-020-2521-4 · Cited by 6,674 · see citing works
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898 · see citing works
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,237 · see citing works
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
Long, Q.-X., Tang, X.-J., Shi, Q.-L., Li, Q., Deng, H.-J., Yuan, J., Hu, J.-L., Xu, W., Zhang, Y., Lv, F.-J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0965-6 · Cited by 2,686 · see citing works
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419 · see citing works
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853 · see citing works
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788 · see citing works
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623 · see citing works
A minimal common outcome measure set for COVID-19 clinical research
Marshall, J. C., Murthy, S., Diaz, J. V., Adhikari, N. K., Angus, D., Arabi, Y. M., Baillie, J. K., Bauer, M. W., Berry, S., Blackwood, B., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30483-7 · Cited by 1,605 · see citing works
Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509 · see citing works
Development of an inactivated vaccine candidate for SARS-CoV-2
Gao, Q., Bao, L., Mao, H., Wang, L., Xu, K., Yang, M., Li, Y., Zhu, L., Wang, N., Lv, Z., et al. (2020) · Science · doi:10.1126/science.abc1932 · Cited by 1,434 · see citing works
Remdesivir for the Treatment of Covid-19 — Preliminary Report
Gillenwater, S., Rahaghi, F., & Hadeh, A. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2022236 · Cited by 1,422 · see citing works
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Chen, P., Nirula, A., Heller, B., Gottlieb, R. L., Boscia, J., Morris, J., Huhn, G., Cardona, J., Mocherla, B., Stosor, V., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029849 · Cited by 1,282 · see citing works
Rogers, T. F., Zhao, F., Huang, D., Beutler, N., Burns, A., He, W.-T., Limbo, O., Smith, C., Song, G., Woehl, J., et al. (2020) · Science · doi:10.1126/science.abc7520 · Cited by 1,230 · cited 1× · see citing works
“Other studies have identified SARS-CoV-2-specific B cells in COVID-19 patients with particular focus on the RBD of the spike protein, mainly for the purpose of cloning neutralizing SARS-CoV-2-specific antibodies ( 4 , 14 , 22 , 47 , 48 ).”
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Brouwer, P. J. M., Caniels, T. G., van der Straten, K., Snitselaar, J. L., Aldon, Y., Bangaru, S., Torres, J. L., Okba, N. M. A., Claireaux, M., Kerster, G., et al. (2020) · Science · doi:10.1126/science.abc5902 · Cited by 1,140 · see citing works
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Ni, L., Ye, F., Cheng, M., Yu, F., Deng, Y., Zhao, H. J., Peng, W., Ge, J., Gou, M., Li, X., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.023 · Cited by 1,069 · see citing works
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Corbett, K. S., Flynn, B., Foulds, K. E., Francica, J. R., Boyoglu-Barnum, S., Werner, A. P., Flach, B., O’Connell, S., Bock, K. W., Minai, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2024671 · Cited by 1,066 · see citing works
Logunov, D. Y., Dolzhikova, I. V., Zubkova, O. V., Tukhvatulin, A. I., Shcheblyakov, D. V., Dzharullaeva, A. S., Grousova, D. M., Erokhova, A. S., Kovyrshina, A. V., Botikov, A. G., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31866-3 · Cited by 1,055 · see citing works
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
Ibarrondo, F. J., Fulcher, J. A., Goodman-Meza, D., Elliott, J., Hofmann, C., Hausner, M. A., Ferbas, K. G., Tobin, N. H., Aldrovandi, G. M., & Yang, O. O. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2025179 · Cited by 1,021 · see citing works
Humoral Immune Response to SARS-CoV-2 in Iceland
Gudbjartsson, D. F., Norddahl, G. L., Melsted, P., Gunnarsdottir, K., Holm, H., Eythorsson, E., Arnthorsson, A. O., Helgason, D., Bjarnadottir, K., Ingvarsson, R. F., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026116 · Cited by 903 · see citing works
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols
Kalina, T., Flores-Montero, J. A., van der Velden, V. H. J., Martin-Ayuso, M., Böttcher, S., Ritgen, M., Almeida, J., Lhermitte, L., Asnafi, V., Mendonça, A., et al. (2012) · Leukemia · doi:10.1038/leu.2012.122 · Cited by 789 · see citing works
Single-Shot Ad26 Vaccine Protects Against SARS-CoV-2 in Rhesus Macaques
Mercado, N. B., Zahn, R., Wegmann, F., Loos, C., Chandrashekar, A., Yu, J., Liu, J., Peter, L., McMahan, K., Tostanoski, L. H., et al. (2020) · Nature · doi:10.1038/s41586-020-2607-z · Cited by 789 · see citing works
Wang, H., Zhang, Y., Huang, B., Deng, W., Quan, Y., Wang, W., Xu, W., Zhao, Y., Li, N., Zhang, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.008 · Cited by 748 · see citing works
Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
Kaneko, N., Kuo, H.-H., Boucau, J., Farmer, J. R., Allard-Chamard, H., Mahajan, V. S., Piechocka-Trocha, A., Lefteri, K., Osborn, M., Bals, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.025 · Cited by 734 · see citing works
Crawford, K. H. D., Eguia, R. T., Dingens, A. S., Loes, A. N., Malone, K. D., Wolf, C. R., Chu, H. Y., Tortorici, M. A., Veesler, D., Murphy, M., et al. (2020) · Viruses · doi:10.3390/v12050513 · Cited by 727 · see citing works
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697 · see citing works
Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19
Rodda, L. B., Netland, J., Shehata, L., Pruner, K. B., Morawski, P. A., Thouvenel, C. D., Takehara, K. K., Eggenberger, J., Hemann, E. A., Waterman, H. R., et al. (2021) · Cell · doi:10.1016/j.cell.2020.11.029 · Cited by 647 · see citing works
Angelini, M. M., Akhlaghpour, M., Neuman, B. W., & Buchmeier, M. J. (2013) · mBio · doi:10.1128/mbio.00524-13 · Cited by 521 · see citing works
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Suthar, M. S., Zimmerman, M. G., Kauffman, R. C., Mantus, G., Linderman, S. L., Hudson, W. H., Vanderheiden, A., Nyhoff, L., Davis, C. W., Adekunle, O., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100040 · Cited by 508 · see citing works
Snijder, E. J., van der Meer, Y., Zevenhoven-Dobbe, J. C., Onderwater, J. J. M., van der Meulen, J., Koerten, H. K., & Mommaas, A. M. (2006) · Journal of Virology · doi:10.1128/jvi.02501-05 · Cited by 506 · see citing works
Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496 · see citing works
Snijder, E. J., Limpens, R. W. A. L., de Wilde, A. H., de Jong, A. W. M., Zevenhoven-Dobbe, J. C., Maier, H. J., Faas, F. F. G. A., Koster, A. J., & Bárcena, M. (2020) · PLOS Biology · doi:10.1371/journal.pbio.3000715 · Cited by 477 · see citing works
Burbelo, P. D., Riedo, F. X., Morishima, C., Rawlings, S. A., Smith, D. M., Das, S., Strich, J. R., Chertow, D. S., Davey, R. T., & Cohen, J. I. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa273 · Cited by 466 · see citing works
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
Juno, J. A., Tan, H.-X., Lee, W. S., Reynaldi, A., Kelly, H. G., Wragg, K., Esterbauer, R., Kent, H. E., Batten, C. J., Mordant, F. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0995-0 · Cited by 437 · see citing works
The establishment of resident memory B cells in the lung requires local antigen encounter
Allie, S. R., Bradley, J., Mudunuru, U., Schultz, M. D., Graf, B. A., Lund, F. E., & Randall, T. D. (2018) · Nature Immunology · doi:10.1038/s41590-018-0260-6 · Cited by 398 · see citing works
Ellebedy, A. H., Jackson, K., Kissick, H. T., Nakaya, H. I., Davis, C. W., Roskin, K. M., McElroy, A. K., Oshansky, C. M., Elbein, R., Thomas, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3533 · Cited by 384 · see citing works
Seydoux, E., Homad, L. J., MacCamy, A. J., Parks, K. R., Hurlburt, N. K., Jennewein, M. F., Akins, N. R., Stuart, A. B., Wan, Y.-H., Feng, J., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.06.001 · Cited by 364 · cited 1× · see citing works
“These antibodies are detectable from approximately 6 days after PCR confirmation of infection, and those directed against spike receptor binding domain (RBD) show neutralizing capacity and hence, can prevent infection ( 15 , 16 ).”
BackgroundBerkowska, M. A., Driessen, G. J. A., Bikos, V., Großerichter-Wagener, C., Σταματόπουλος, Κ., Cerutti, A., He, B., Biermann, K., Lange, J. F., van der Burg, M., et al. (2011) · Blood · doi:10.1182/blood-2011-04-345579 · Cited by 360 · see citing works
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
Meyts, I., Bucciol, G., Quinti, I., Neven, B., Fischer, A., Seoane, E., López‐Granados, E., Gianelli, C., Robles‐Marhuenda, Á., Jeandel, P.-Y., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.09.010 · Cited by 340 · see citing works
Laboratory Assays for Epstein-Barr Virus-Related Disease
Gulley, M. L., & Tang, W. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080023 · Cited by 325 · see citing works
Grzelak, L., Temmam, S., Planchais, C., Demeret, C., Tondeur, L., Huon, C., Guivel-Benhassine, F., Staropoli, I., Chazal, M., Dufloo, J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc3103 · Cited by 310 · see citing works
Not just antibodies: B cells and T cells mediate immunity to COVID-19
Cox, R. J., & Brokstad, K. A. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00436-4 · Cited by 291 · see citing works
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection
Hachim, A., Kavian, N., Cohen, C. A., Chin, A. W. H., Chu, D. K. W., Mok, C. K. P., Tsang, O. T., Yeung, Y. C., Perera, R. A. P. M., Poon, L. L. M., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0773-7 · Cited by 262 · see citing works
Rapid and Massive Virus-Specific Plasmablast Responses during Acute Dengue Virus Infection in Humans
Wrammert, J., Onlamoon, N., Akondy, R. S., Perng, G., Polsrila, K., Chandele, A., Kwissa, M., Pulendran, B., Wilson, P. C., Wittawatmongkol, O., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06075-11 · Cited by 258 · see citing works
Hsueh, P., Huang, L., Chen, P., Kao, C., & Yang, P. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01009.x · Cited by 255 · see citing works
Onodera, T., Takahashi, Y., Yokoi, Y., Ato, M., Kodama, Y., Hachimura, S., Kurosaki, T., & Kobayashi, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115369109 · Cited by 250 · see citing works
Koutsakos, M., Wheatley, A. K., Loh, L., Clemens, E. B., Sant, S. A., Nüssing, S., Fox, A., Chung, A. W., Laurie, K., Hurt, A. C., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan8405 · Cited by 237 · see citing works
Overview of the Diagnosis of Cytomegalovirus Infection
Ross, S. A., Novák, Z., Pati, S., & Boppana, S. B. (2011) · Infectious Disorders - Drug Targets · doi:10.2174/187152611797636703 · Cited by 234 · see citing works
Leung, D. T. M., Tam, F. C. H., Ma, C. H., Chan, P. K. S., Cheung, J. L. K., Niu, H., Tam, J. S., & Lim, P. L. (2004) · The Journal of Infectious Diseases · doi:10.1086/422040 · Cited by 207 · see citing works
Nguyen-Contant, P., Embong, A. K., Kanagaiah, P., Chaves, F. A., Yang, H., Branche, A. R., Topham, D. J., & Sangster, M. Y. (2020) · mBio · doi:10.1128/mbio.01991-20 · Cited by 204 · see citing works
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood
Ng, D. L., Goldgof, G. M., Shy, B. R., Levine, A. G., Balcerek, J., Bapat, S. P., Prostko, J. C., Rodgers, M. A., Coller, K. E., Pearce, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18468-8 · Cited by 185 · see citing works
Distinct germinal center selection at local sites shapes memory B cell response to viral escape
Adachi, Y., Onodera, T., Yamada, Y., Daio, R., Tsuiji, M., Inoue, T., Kobayashi, K., Kurosaki, T., Ato, M., & Takahashi, Y. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142284 · Cited by 174 · see citing works
The Laboratory Diagnosis of Hepatitis B Virus
Krajden, M., McNabb, G., & Petric, M. (2005) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2005/450574 · Cited by 172 · see citing works
Immunological memory to SARS-CoV-2 assessed for up to eight months after infectionPreprint
Dan, J., Mateus, J., Kato, Y., Hastie, K., Yu, E., Faliti, C. E., Grifoni, A., Ramirez, S., Haupt, S., Frazier, A., et al. (2020) · bioRxiv · doi:10.1101/2020.11.15.383323 · Cited by 147 · see citing works
Andrews, S. F., Chambers, M. J., Schramm, C. A., Plyler, J. R., Raab, J. E., Kanekiyo, M., Gillespie, R. A., Ransier, A., Darko, S. W., Hu, J., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.024 · Cited by 141 · see citing works
Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee
Patel, M. M., Thornburg, N. J., Stubblefield, W. B., Talbot, H. K., Coughlin, M. M., Feldstein, L. R., & Self, W. H. (2020) · JAMA · doi:10.1001/jama.2020.18796 · Cited by 125 · see citing works
Immunological memory to SARS-CoV-2 assessed for up to eight months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2020) · eScholarship (California Digital Library) · Cited by 121 · see citing works
Expansion of atypical memory B cells is a prominent feature of COVID-19
Oliviero, B., Varchetta, S., Mele, D., Mantovani, S., Cerino, A., Perotti, C. G., Ludovisi, S., & Mondelli, M. U. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00542-2 · Cited by 104 · see citing works
Cross-lineage protection by human antibodies binding the influenza B hemagglutinin
Liu, Y., Tan, H., Koutsakos, M., Jegaskanda, S., Esterbauer, R., Tilmanis, D., Aban, M., Kedzierska, K., Hurt, A. C., Kent, S. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08165-y · Cited by 88 · see citing works
Circulating Human CD27−IgA+ Memory B Cells Recognize Bacteria with Polyreactive Igs
Berkowska, M. A., Schickel, J., Großerichter-Wagener, C., de Ridder, D., Ng, Y. S., van Dongen, J. J. M., Meffre, E., & van Zelm, M. C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402708 · Cited by 82 · see citing works
Zhou, T., Teng, I., Olia, A. S., Cerutti, G., Gorman, J., Nazzari, A. F., Shi, W., Tsybovsky, Y., Wang, L., Wang, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108322 · Cited by 69 · see citing works
Newell, K. L., Clemmer, D. C., Cox, J. B., Kayode, Y. I., Zoccoli-Rodriguez, V., Taylor, H. E., Endy, T. P., Wilmore, J. R., & Winslow, G. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244855 · Cited by 67 · see citing works
Huang, L., Chiu, C., Yeh, S., Huang, W., Hsueh, P., Yang, W., Yang, J., Su, I., Chang, S., & Chen, P. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20096 · Cited by 67 · see citing works
Vietheer, P. T., Boo, I., Gu, J., McCaffrey, K., Edwards, S. J., Owczarek, C. M., Hardy, M. P., Fabri, L., Poumbourios, P., & Drummer, H. E. (2016) · Hepatology · doi:10.1002/hep.28989 · Cited by 66 · see citing works
Self-citationEdwards, E. S. J., Bosco, J. J., Aui, P. M., Stirling, R. G., Cameron, P. U., Chatelier, J., Hore‐Lacy, F., O’Hehir, R. E., & van Zelm, M. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02593 · Cited by 57 · see citing works
Self-citationde Jong, B. G., IJspeert, H., Marques, L., van der Burg, M., van Dongen, J. J. M., Loos, B. G., & van Zelm, M. C. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.43 · Cited by 54 · see citing works
Huang, K.-Y. A., Li, C. K., Clutterbuck, E., Chui, C., Wilkinson, T. M. A., Gilbert, A., OXFORD, J. S., Lambkin‐Williams, R., Lin, T., McMichael, A. J., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit650 · Cited by 52 · see citing works
Wheatley, A. K., Kristensen, A. B., Lay, W. N., & Kent, S. J. (2016) · Scientific Reports · doi:10.1038/srep26478 · Cited by 38 · see citing works
Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019
Huang, M., Lu, Q., Zhao, H., Zhang, Y., Sui, Z., Fang, L., Liu, D., Sun, X., Peng, K., Liu, W. Y., et al. (2020) · Cell Discovery · doi:10.1038/s41421-020-00209-2 · Cited by 31 · see citing works
Rapid detection of SARS‐CoV‐2‐specific memory T‐cell immunity in recovered COVID‐19 cases
Lineburg, K. E., Srihari, S., Altaf, M., Swaminathan, S., Panikkar, A., Raju, J., Crooks, P., Ambalathingal, G. R., Martins, J. P., Matthews, K. K., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1219 · Cited by 26 · see citing works
Structure of general-population antibody titer distributions to influenza A virus
Nhat, N. T. D., Todd, S., de Bruin, E., Thao, T. T. N., Vy, N. H. T., Tran, Q. M., Vinh, D. N., van Beek, J., Ánh, P. H., Lam, H. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06177-0 · Cited by 24 · see citing works
Distinct B cell subsets give rise to antigen-specific antibody responses against SARS-CoV-2Preprint
Wilson, P. C., Stamper, C. T., Dugan, H. L., Li, L., Asby, N. W., Halfmann, P., Guthmiller, J. J., Zheng, N., Huang, M., Stovicek, O., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-80476/v1 · Cited by 21 · see citing works
Zhou, T., Teng, I., Olia, A. S., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3639618 · Cited by 20 · see citing works
Newell, K. L., Clemmer, D. C., Cox, J. B., et al. (2020) · medRxiv · doi:10.1101/2020.09.04.20187724 · Cited by 18 · see citing works
Hartley, G. E., Edwards, E. S. J., Bosco, J. J., Ojaimi, S., Stirling, R. G., Cameron, P. U., Flanagan, K. L., Plebanski, M., Hogarth, P. M., O’Hehir, R. E., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1199 · Cited by 18 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [29]Australian Immunisation Handbook, 2018. Vol. 2019. Australian Government- Department of Health.
Cited by
Sorted by citations
Goel, R. R., Apostolidis, S. A., Painter, M. M., Mathew, D., Pattekar, A., Kuthuru, O., Gouma, S., Hicks, P., Meng, W., Rosenfeld, A. M., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abi6950 · Cited by 655 · see citing works
Geers, D., Shamier, M. C., Bogers, S., den Hartog, G., Gommers, L., Nieuwkoop, N. N., Schmitz, K. S., Rijsbergen, L. C., van Osch, J. A. T., Dijkhuizen, E., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj1750 · Cited by 529 · see citing works
Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
Sokal, A., Chappert, P., Barba-Spaeth, G., Roeser, A., Fourati, S., Azzaoui, I., Vandenberghe, A., Fernandez, I., Meola, A., Bouvier-Alias, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.01.050 · Cited by 340 · see citing works
Afkhami, S., D’Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.005 · Cited by 307 · see citing works
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Mistry, P., Barmania, F., Mellet, J., Peta, K. T., Strydom, A., Viljoen, I. M., James, W., Gordon, S., & Pepper, M. S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.809244 · Cited by 293 · see citing works
Antibodies to combat viral infections: development strategies and progress
Pantaleo, G., Correia, B. E., Fenwick, C. W., Joo, V., & Perez, L. H. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00495-3 · Cited by 286 · see citing works
Rincón-Arévalo, H., Choi, M., Stefanski, A., Halleck, F., Weber, U., Szelinski, F., Jahrsdörfer, B., Schrezenmeier, H., Ludwig, C., Sattler, A., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj1031 · Cited by 271 · see citing works
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
Cromer, D., Juno, J. A., Khoury, D., Reynaldi, A., Wheatley, A. K., Kent, S. J., & Davenport, M. P. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00550-x · Cited by 265 · see citing works
Sherina, N., Piralla, A., Du, L., Wan, H., Kumagai‐Braesch, M., Andréll, J., Braesch‐Andersen, S., Cassaniti, I., Percivalle, E., Sarasini, A., et al. (2021) · Med · doi:10.1016/j.medj.2021.02.001 · Cited by 188 · see citing works
Anand, S., Prévost, J., Nayrac, M., Beaudoin-Bussières, G., Benlarbi, M., Gasser, R., Brassard, N., Laumaea, A., Gong, S., Bourassa, C., et al. (2021) · bioRxiv · doi:10.1016/j.xcrm.2021.100290 · Cited by 177 · see citing works
Adaptive Immune Responses and Immunity to SARS-CoV-2
Primorac, D., Vrdoljak, K., Brlek, P., Pavelić, E., Molnar, V., Matišić, V., Ivkošić, I. E., & Parčina, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.848582 · Cited by 151 · see citing works
Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains
Rella, S. A., Kulikova, Y. A., Dermitzakis, E. T., & Kondrashov, F. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-95025-3 · Cited by 136 · see citing works
Dugan, H. L., Stamper, C. T., Li, L., Changrob, S., Asby, N. W., Halfmann, P. J., Zheng, N.-Y., Huang, M., Shaw, D. G., Cobb, M. S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.001 · Cited by 134 · see citing works
Antibody and B cell responses to SARS-CoV-2 infection and vaccination
Röltgen, K., & Boyd, S. D. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.009 · Cited by 136 · see citing works
Vaccines and allergic reactions: The past, the current COVID‐19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M. M., Jain, S., Diamant, Z., Jeseňák, M., Rabin, R. L., Vieths, S., Agache, I. O., Akdiş, M., et al. (2021) · Allergy · doi:10.1111/all.14840 · Cited by 117 · see citing works
Self-citationReinfection With SARS-CoV-2: Implications for Vaccines
Cohen, J. I., & Burbelo, P. D. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1866 · Cited by 109 · see citing works
Aziz, N. A., Corman, V. M., Echterhoff, A. K. C., Müller, M. A., Richter, A. M., Schmandke, A., Schmidt, M. L., Schmidt, T. H., de Vries, F. M., Drosten, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22351-5 · Cited by 99 · see citing works
Chen, Y., Yin, S., Tong, X., Tao, Y., Ni, J., Pan, J., Li, M., Wan, Y., Mao, M., Xiong, Y., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.10.006 · Cited by 96 · see citing works
B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity
Lapuente, D., Winkler, T., & Tenbusch, M. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01095-w · Cited by 91 · see citing works
Immunity to SARS-CoV-2 up to 15 months after infection
Marcotte, H., Piralla, A., Zuo, F., Du, L., Cassaniti, I., Wan, H., Kumagai‐Braesch, M., Andréll, J., Percivalle, E., Sammartino, J. C., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103743 · Cited by 79 · see citing works
Koerber, N., Priller, A., Yazici, S., Bauer, T., Cheng, C., Mijočević, H., Wintersteller, H., Jeske, S. D., Vogel, E., Feuerherd, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27649-y · Cited by 72 · see citing works
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
Kapłonek, P., Wang, C., Bartsch, Y. C., Fischinger, S., Gorman, M. J., Bowman, K. A., Kang, J., Dayal, D., Martin, P., Nowak, R. P., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj2901 · Cited by 76 · see citing works
The role of B cells in COVID-19 infection and vaccination
Chen, S., Guan, F., Candotti, F., Benlagha, K., Câmara, N. O. S., Herrada, A. A., James, L. K., Lei, J., Miller, H., Kubo, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.988536 · Cited by 74 · see citing works
Antibody Responses to Natural SARS-CoV-2 Infection or after COVID-19 Vaccination
Altawalah, H. (2021) · Vaccines · doi:10.3390/vaccines9080910 · Cited by 71 · see citing works
COVID-19 in B Cell-Depleted Patients After Rituximab: A Diagnostic and Therapeutic Challenge
Furlan, A., Forner, G., Cipriani, L., Vian, E., Rigoli, R., Gherlinzoni, F., & Scotton, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763412 · Cited by 74 · see citing works
Lin, Y., Wang, G., Shen, Y., Wang, Z.-Y., Zhan, B.-D., Duan, L., Lu, B., Shi, C., Gao, Y., Peng, H.-H., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab255 · Cited by 68 · see citing works
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
Hamady, A., Lee, J., & Loboda, Z. (2021) · Infection · doi:10.1007/s15010-021-01664-z · Cited by 65 · see citing works
SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus
Matusali, G., Colavita, F., Lapa, D., Meschi, S., Bordi, L., Piselli, P., Gagliardini, R., Corpolongo, A., Nicastri, E., Antinori, A., et al. (2021) · Viruses · doi:10.3390/v13040655 · Cited by 68 · see citing works
Terpos, E., Stellas, D., Rosati, M., Sergentanis, T. Ν., Hu, X., Politou, M., Pappa, V., Ntanasis‐Stathopoulos, I., Karaliota, S., Bear, J., et al. (2021) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2021.05.010 · Cited by 66 · see citing works
Duration of post–COVID-19 symptoms is associated with sustained SARS-CoV-2–specific immune responses
Files, J. K., Sarkar, S., Fram, T., Boppana, S., Sterrett, S., Qin, K., Bansal, A., Long, D. M., Sabbaj, S., Kobie, J. J., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.151544 · Cited by 66 · see citing works
Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine
Kramer, K. J., Wilfong, E., Voss, K., Barone, S. M., Shiakolas, A. R., Raju, N., Roe, C. E., Suryadevara, N., Walker, L. M., Wall, S. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-022-31142-5 · Cited by 53 · see citing works
Feldman, J. E., Bals, J., Altomare, C. G., Denis, K. S., Lam, E. C., Hauser, B. M., Ronsard, L., Sangesland, M., Moreno, T. B., Okonkwo, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abl5842 · Cited by 58 · see citing works
Dobaño, C., Ramírez‐Morros, A., Alonso, S., Vidal‐Alaball, J., Ruiz‐Olalla, G., Vidal, M., Rubio, R., Cascant, E., Parras, D., Melero, N. R., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02032-2 · Cited by 58 · see citing works
Byazrova, M. G., Yusubalieva, G. M., Spiridonova, A. A., Efimov, G. A., Mazurov, D. V., Baranov, K. O., Baklaushev, V. P., & Filatov, A. V. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1245 · Cited by 52 · see citing works
Haslwanter, D., Dieterle, M. E., Wec, A. Z., O’Brien, C. M., Sakharkar, M., Florez, C., Tong, K., Rappazzo, C. G., Lasso, G., Vergnolle, O., et al. (2021) · mBio · doi:10.1128/mbio.02473-21 · Cited by 55 · see citing works
Favresse, J., Eucher, C., Elsen, M., Gillot, C., Eeckhoudt, S. V., Dogné, J., & Douxfils, J. (2021) · Microorganisms · doi:10.3390/microorganisms9030556 · Cited by 54 · see citing works
Korosec, C. S., Farhang‐Sardroodi, S., Dick, D. W., Gholami, S., Ghaemi, M. S., Moyles, I. R., Craig, M., Ooi, H. K., & Heffernan, J. M. (2022) · Scientific Reports · doi:10.1038/s41598-022-25134-0 · Cited by 56 · see citing works
Literature Review of Omicron: A Grim Reality Amidst COVID-19
Arora, S., Grover, V., Saluja, P., Algarni, Y. A., Saquib, S. A., Asif, S. M., Batra, K., Alshahrani, M. Y., Das, G., Jain, R., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10020451 · Cited by 53 · see citing works
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
Yu, H., Guan, F., Miller, H., Lei, J., & Liu, C. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2164219 · Cited by 50 · see citing works
SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques
Garrido, C., Curtis, A. D., Dennis, M. L., Pathak, S., Gao, H., Montefiori, D. C., Tomai, M. A., Fox, C. B., Kozlowski, P. A., Scobey, T., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj3684 · Cited by 44 · see citing works
SARS-CoV-2 Antigens Expressed in Plants Detect Antibody Responses in COVID-19 Patients
Makatsa, M. S., Tincho, M. B., Wendoh, J. M., Ismail, S. D., Nesamari, R., Pêra, F. F. P. G., Beer, S., David, A., Jugwanth, S., Gededzha, M. P., et al. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.589940 · Cited by 46 · see citing works
COVID ‐19 and plasma cells: Is there long‐lived protection?*
Nguyen, D. C., Lamothe, P. A., Woodruff, M. C., Saini, A. S., Faliti, C. E., Sanz, I., & Lee, F. E.-H. (2022) · Immunological Reviews · doi:10.1111/imr.13115 · Cited by 44 · see citing works
Herman, J. D., Wang, C., Loos, C., Yoon, H., Rivera, J., Dieterle, M. E., Haslwanter, D., Jangra, R. K., Bortz, R. H., Bar, K. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27201-y · Cited by 39 · see citing works
Coppeta, L., Ferrari, C., Somma, G., Mazza, A., D’Ancona, U., Marcuccilli, F., Grelli, S., Aurilio, M. T., Pietroiusti, A., Magrini, A., et al. (2022) · Vaccines · doi:10.3390/vaccines10020141 · Cited by 44 · see citing works
The immunopathology of B lymphocytes during stroke-induced injury and repair
Malone, M. K., Ujas, T. A., Britsch, D. R. S., Cotter, K. M., Poinsatte, K., & Stowe, A. M. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00971-3 · Cited by 44 · see citing works
Fazolo, T., Lima, K. R., da Fontoura, J. C., de Souza, P. O., Hilario, G., Zorzetto, R., Júnior, L. R., Pscheidt, V. M., Neto, J. D. C. F., Haubert, A. F., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27120-y · Cited by 40 · see citing works
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity
Tangye, S. G., Abel, L., Al-Muhsen, S., Aiuti, A., Al‐Muhsen, S., Al‐Mulla, F., Anderson, M. S., Andreakos, E., Novelli, A., Arias, A. A., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.11.010 · Cited by 38 · see citing works
Guo, W., Duan, K., Zhang, Y., Yuan, Z., Zhang, Y., Wang, Z., Zhao, D., Zhang, H., Xie, Z., Li, X., et al. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.101010 · Cited by 36 · see citing works
Zhu, L., Xu, X. P., Zhu, B., Guo, X., Xu, K., Song, C., Fu, J., Yu, H., Kong, X., Peng, J., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00590-21 · Cited by 38 · see citing works
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination
Koutsakos, M., Lee, W. S., Wheatley, A. K., Kent, S. J., & Juno, J. A. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.5mr0821-464r · Cited by 36 · see citing works
Jeffery-Smith, A., Burton, A. R., Lens, S., Rees-Spear, C., Davies, J. E., Patel, M., Gopal, R., Muir, L., Aiano, F., Doores, K. J., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci152042 · Cited by 36 · see citing works
Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
Dehgani‐Mobaraki, P., Zaidi, A. K., Yadav, N., Floridi, A., & Floridi, E. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108814 · Cited by 34 · see citing works
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
Shafqat, A., Shafqat, S., Alsalameh, S., Kashir, J., AlKattan, K. M., & Yaqinuddin, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.835104 · Cited by 36 · see citing works
Busà, R., Sorrentino, M. C., Russelli, G., Amico, G., Miceli, V., Miele, M., Bella, M. D., Timoneri, F., Gallo, A., Zito, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.856657 · Cited by 34 · see citing works
Molodtsov, I. A., Kegeles, E., Mitin, A. N., Mityaeva, O. N., Musatova, O. E., Panova, A. E., Pashenkov, M. V., Peshkova, I. O., Alsalloum, A., Asaad, W., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac278 · Cited by 33 · see citing works
Vaquero, S. T., de Campos‐Mata, L., Ramada, J. M., Díaz, P., Navarro‐Barriuso, J., Ribas‐Llauradó, C., Melero, N. R., Carolis, C., Cerutti, A., Gimeno, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.737083 · Cited by 33 · see citing works
B lymphocytes in COVID-19: a tale of harmony and discordance
Mansourabadi, A. H., Aghamajidi, A., Dorfaki, M., Keshavarz, F., Shafeghat, Z., Moazzeni, A., Arab, F. L., Rajabian, A., Roozbehani, M., Falak, R., et al. (2023) · Archives of Virology · doi:10.1007/s00705-023-05773-y · Cited by 33 · see citing works
Impact of B.1.1.7 variant mutations on antibody recognition of linear SARS-CoV-2 epitopesPreprint
Haynes, W. A., Kamath, K., Lucas, C. G. D. O., Shon, J. C., & Iwasaki, A. (2021) · medRxiv · doi:10.1101/2021.01.06.20248960 · Cited by 33 · see citing works
Immune Imprinting and Implications for COVID-19
Zhou, Z., Barrett, J., & He, X. (2023) · Vaccines · doi:10.3390/vaccines11040875 · Cited by 32 · see citing works
Prior COVID-19 protects against reinfection, even in the absence of detectable antibodies
Breathnach, A. S., Duncan, C. J. A., Bouzidi, K. E., Hanrath, A. T., Payne, B. A. I., Randell, P. A., Habibi, M. S., Riley, P. A., Planche, T., Busby, J., et al. (2021) · Journal of Infection · doi:10.1016/j.jinf.2021.05.024 · Cited by 30 · see citing works
Reyes, R. A., Clarke, K., Gonzales, S. J., Cantwell, A. M., Garza, R., Catano, G., Tragus, R. E., Patterson, T. F., Bol, S. M., & Bunnik, E. M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0261656 · Cited by 32 · see citing works
Castro, L. C. E., Gomes, A., Serrano, M., Pereira, A. H. G., Ribeiro, R., Napoleão, P., Domingues, I., Silva, C., Fanczal, J., Afonso, Â., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149619 · Cited by 29 · see citing works
Chen, J., Wang, B., Caserto, J. S., Shariati, K., Cao, P., Pan, Y., Xu, Q., & Ma, M. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202101714 · Cited by 30 · see citing works
Saliva SARS-CoV-2 Antibody Prevalence in Children
Keuning, M. W., Grobben, M., de Groen, A.-E. C., Jong, E. P. B.-D., Bijlsma, M. W., Cohen, S., Felderhof, M. K., de Groof, F., Molanus, D., Oey, N. A., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00731-21 · Cited by 30 · see citing works
Jeffery-Smith, A., Burton, A. R., Lens, S., Rees-Spear, C., Davies, J. E., Patel, M., Gopal, R., Muir, L., Aiano, F., Doores, K. J., et al. (2022) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 30 · see citing works
Winklmeier, S., Eisenhut, K., Taskin, D., Rübsamen, H., Gerhards, R., Schneider, C., Wratil, P. R., Stern, M., Eichhorn, P., Keppler, O. T., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103659 · Cited by 30 · see citing works
Update on inborn errors of immunity
IJspeert, H., Edwards, E. S. J., O’Hehir, R. E., Dalm, V. A. S. H., & van Zelm, M. C. (2024) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2024.12.1075 · Cited by 29 · see citing works
Self-citationHumoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
Lee, E.-J., & Oh, J. E. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0075 · Cited by 29 · see citing works
Chen, W., Zhang, L., Li, J., Bai, S., Wang, Y., Zhang, B., Zheng, Q., Chen, M., Zhao, W., & Wu, J. (2022) · Immunology · doi:10.1111/imm.13531 · Cited by 29 · see citing works
Jiang, W., Johnson, D., Adekunle, R. O., Heather, H., Xu, W., Cong, X. S., Wu, X., Fan, H., Andersson, L., Robertson, J., et al. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28134 · Cited by 29 · see citing works
Jacobsen, E., Fabricius, D., Class, M., Topfstedt, F., Lorenzetti, R., Janowska, I., Schmidt, F., Staniek, J., Zernickel, M., Stamminger, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35055-1 · Cited by 29 · see citing works
Wang, L., Xu, T., Stoecker, T. H., Horst Stöcker, B., Jiang, Y., & Zhou, K. (2021) · Machine Learning Science and Technology · doi:10.1088/2632-2153/ac0314 · Cited by 28 · see citing works
Interleukin-21 in Viral Infections
Asao, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179521 · Cited by 31 · see citing works
Infection, recovery and re-infection of farmed mink with SARS-CoV-2
Rasmussen, T. B., Fonager, J., Jørgensen, C. S., Lassaunière, R., Hammer, A. S., Quaade, M. L., Boklund, A. E., Lohse, L., Strandbygaard, B., Rasmussen, M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1010068 · Cited by 28 · see citing works
scINSIGHT for interpreting single-cell gene expression from biologically heterogeneous data
Qian, K., Fu, S., Li, H., & Li, W. V. (2022) · Genome biology · doi:10.1186/s13059-022-02649-3 · Cited by 26 · see citing works
A Review on Immunological Responses to SARS-CoV-2 and Various COVID-19 Vaccine Regimens
Upreti, S., & Samant, M. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03323-w · Cited by 29 · see citing works
Eberhardt, K. A., Dewald, F., Heger, E., Gieselmann, L., Vanshylla, K., Wirtz, M., Kleipass, F., Johannis, W., Schommers, P., Gruell, H., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9040733 · Cited by 25 · see citing works
Bai, J., Chiba, A., Murayama, G., Kuga, T., Tamura, N., & Miyake, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.786586 · Cited by 27 · see citing works
Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
de Assis, F. L., Hoehn, K. B., Zhang, X., Kardava, L., Smith, C. D., Merhebi, O. E., Buckner, C. M., Trihemasava, K., Wang, W., Seamon, C. A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112780 · Cited by 26 · see citing works
Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines
Abdel-Moneim, A. S., Abdelwhab, E. M., & Memish, Z. A. (2021) · Virology · doi:10.1016/j.virol.2021.02.007 · Cited by 27 · see citing works
Ligotti, M. E., Pojero, F., Accardi, G., Aiello, A., Caruso, C., Duro, G., & Candore, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.725606 · Cited by 25 · see citing works
Wolf, C., Köppert, S., Becza, N., Küerten, S., Kirchenbaum, G. A., & Lehmann, P. (2022) · Cells · doi:10.3390/cells11223662 · Cited by 23 · see citing works
PLAN B for immunotherapy: Promoting and leveraging anti-tumor B cell immunity
Shi, Y. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.09.028 · Cited by 25 · see citing works
Ocrelizumab for the Treatment of Multiple Sclerosis: Safety, Efficacy, and Pharmacology
Mancinelli, C. R., Rossi, N. D., & Capra, R. (2021) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s282390 · Cited by 24 · see citing works
SARS‐CoV‐2 memory B and T cell profiles in mild COVID‐19 convalescent patients
Gurevich, M., Zilkha‐Falb, R., Sonis, P., Magalashvili, D., Menascu, S., Flechter, S., Dolev, M., Mandel, M., & Achiron, A. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.12.309 · Cited by 24 · see citing works
Jutel, M., Torres, M. J., Palomares, Ó., Akdiş, C. A., Eiwegger, T., Untersmayr, E., Barber, D., Zemelka‐Wiącek, M., Kosowska, A., Palmer, E. N., et al. (2022) · Allergy · doi:10.1111/all.15252 · Cited by 24 · see citing works
Lavezzo, E., Pacenti, M., Manuto, L., Boldrin, C., Cattai, M., Grazioli, M., Bianca, F., Sartori, M., Caldart, F., Castelli, G., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01066-2 · Cited by 22 · see citing works
Sustained seropositivity up to 20.5 months after COVID-19
Dobaño, C., Ramírez‐Morros, A., Alonso, S., Rubio, R., Ruiz‐Olalla, G., Vidal‐Alaball, J., Macià, D., Catalina, Q. M., Vidal, M., Fuster‐Casanovas, A., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02570-3 · Cited by 27 · see citing works
Maghsood, F., Vanan, A. G., Yadegari, H., Golsaz‐Shirazi, F., Amiri, M. M., & Shokri, F. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2431 · Cited by 24 · see citing works
Genetic Evidence and Host Immune Response in Persons Reinfected with SARS-CoV-2, Brazil
Rodrigues, N. F., da Silva, A. D. P. D., dos Santos, M. C., Saraiva, F., Ferreira, M. A., Gesto, J. S. M., Rodrigues, D. A. S., Vale, A. M., de Azevedo, I. G., Soares, V. C., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2705.204912 · Cited by 24 · see citing works
COVID-19 pandemic: the delta variant, T-cell responses, and the efficacy of developing vaccines
Biswas, B. K., Chattopadhyay, S., Hazra, S., Hansda, A. K., & Goswami, R. (2022) · Inflammation Research · doi:10.1007/s00011-022-01555-5 · Cited by 25 · see citing works
Immune memory to SARS-CoV-2 Omicron BA.1 breakthrough infections: To change the vaccine or not?
van Zelm, M. C. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq5901 · Cited by 23 · see citing works
Lippi, G., Sciacovelli, L., Trenti, T., & Plebani, M. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0038 · Cited by 22 · see citing works
Miniaturized single-cell technologies for monoclonal antibody discovery
Lent, J. V., Breukers, J., Ven, K., Ampofo, L., Horta, S., Pollet, F., Imbrechts, M., Geukens, N., Vanhoorelbeke, K., Declerck, P. J., et al. (2021) · Lab on a Chip · doi:10.1039/d1lc00243k · Cited by 22 · see citing works
Older adults: panoramic view on the COVID-19 vaccination
Andryukov, B. G., & Besednova, N. N. (2021) · AIMS Public Health · doi:10.3934/publichealth.2021030 · Cited by 21 · see citing works
Affinity Tag Coating Enables Reliable Detection of Antigen-Specific B Cells in Immunospot Assays
Köppert, S., Wolf, C., Becza, N., Sautto, G. A., Franke, F., Küerten, S., Ross, T. M., Lehmann, P., & Kirchenbaum, G. A. (2021) · Cells · doi:10.3390/cells10081843 · Cited by 19 · see citing works
van Zelm, M. C., McKenzie, C. I., Varese, N. P., Rolland, J. M., & O’Hehir, R. E. (2021) · Allergy · doi:10.1111/all.15036 · Cited by 20 · see citing works
Self-citationByazrova, M. G., Викторович, К. С., Astakhova, E. A., Николаевна, Б. Т., Efimov, G. A., Chikaev, A. N., Kolotygin, I. O., Gorchakov, A. A., Taranin, A. V., & Filatov, A. V. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840707 · Cited by 19 · see citing works
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial
Sahly, H. M. E., Baden, L. R., Essink, B. J., Montefiori, D. C., McDermont, A., Rupp, R. E., Lewis, M., Swaminathan, S., Griffin, C., Fragoso, V. G., et al. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac188 · Cited by 21 · see citing works
Tissue immunity to SARS‐CoV‐2: Role in protection and immunopathology*
Rybkina, K., Davis‐Porada, J., & Färber, D. L. (2022) · Immunological Reviews · doi:10.1111/imr.13112 · Cited by 19 · see citing works
- Authors
- Hartley, G. E., Edwards, E. S. J., Aui, P. M., Varese, N., Stojanovic, S., McMahon, J., Peleg, A. Y., Boo, I., Drummer, H. E., Hogarth, P. M., O’Hehir, R. E., & van Zelm, M. C.
- Affiliations
- Monash University (AU)
- The Alfred Hospital (AU)
- Burnet Institute (AU)
- Department of Immunology and Pathology, Monash University, Melbourne, VIC, Australia.
- ORCID
- Venue
- Science Immunology
- Published
- 2020-12-18
- Volume
- 5
- Issue
- 54
- ISSN
- 2470-9468 (ISSN-L)
- PMC
- PMC7877496
- OpenAlex
- W3117773316
- Cited by
- 296
- References
- 77
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 22 · 2023: 36 · 2022: 92 · 2021: 125 · 2020: 1
- FWCI
- 8.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Science Immunology (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- National Health and Medical Research Council (1117687)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, memory B cells, nucleocapsid protein, spike protein, receptor binding domain, convalescence, antibody response, T follicular helper cells, long-term immune memory
- MeSH terms
- Protein Domains, COVID-19, SARS-CoV-2, Coronavirus Nucleocapsid Proteins, Adult, Aged, Antibodies, Viral, B-Lymphocytes, Female, Humans, Immunoglobulin G, Immunoglobulin M, Immunologic Memory, Male, Middle Aged, Phosphoproteins, Spike Glycoprotein, Coronavirus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
